Réf. :HematoStat.net ; 2 (6) : R48 Ram R, Grisariu S, Shargian-Alon L, Amit O, Bar-On Y, Stepensky P, et al. Toxicity and efficacy of chimeric antigen receptor T-cell therapy […]

Réf. :HematoStat.net ; 2 (6) : R47 Kuter DJ, Efraim M, Mayer J, Trněný M, McDonald V, Bird R, et al. Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia. N […]

Réf. :HematoStat.net ; 2 (6) : R46 Bachy E, Houot R, Feugier P, Bouabdallah K, Bouabdallah R, Virelizier EN, et al. Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma […]

Réf. :HematoStat.net ; 2 (6) : R45 de Tute RM, Pawlyn C, Cairns DA, Davies FE, Menzies T, Rawstron A, et al. Minimal Residual Disease After Autologous Stem-Cell Transplant for […]